Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsDendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
/in Dendritic Cells, International PublicationsImproving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
/in Dendritic Cells, Hyperthermia, International PublicationsDendritic Cells as Pharmacological Tools for Cancer Immunotherapy
/in Dendritic Cells, International PublicationsImmunotherapy for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsLenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
/in Dendritic Cells, International Publications, Multiple MyelomaPancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
/in Dendritic Cells, International Publications, Pancreatic CancerA pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
/in Dendritic Cells, International Publications, Pancreatic CancerIrradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer